Rifamycin (Rifamycin SV) is an orally active ansamycin antibiotic . Rifamycin inhibits DNA-dependent RNA synthesis . Rifamycin has antibacterial activity against Mycobacterium tuberculosis . Rifamycin interferes with hepatic bile acid metabolism. Rifamycin has anti-inflammatory effects. Rifamycin can be used in the study of Mycobacterium tuberculosis , Bacteroides fragilis infection , and Lipopolysaccharide ( HY-D1056B3 )-induced inflammation.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > DNA/RNA Synthesis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.